Investments
170Portfolio Exits
41Funds
7Partners & Customers
2Service Providers
1About Kaiser Permanente Ventures
Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, invests in medical devices, health care services and health care information technology companies.
Latest Kaiser Permanente Ventures News
Nov 28, 2023
Gynesonics – a women’s healthcare company focused on developing minimally invasive solutions for symptomatic uterine fibroids – recently announced that it has secured an incremental $42.5 million in financing (total of $67.2 million inclusive of initial April 2023 financing). The funding round was led by existing Gynesonics investors Amzak Health, Endeavour Vision, Kaiser Permanente Ventures, Runway Growth Capital, and Bain Capital, with new investments coming from MVM Partners and several other healthcare investors excited about Gynesonics’ commercial advances. As pioneers in women’s health, Gynesonics is committed to developing and delivering minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications. And Gynesonics’ flagship product – the Sonata System – is the first FDA-cleared medical device for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, a medical condition affecting roughly 80% of adult women. Before the Sonata System, fibroid removal was limited to invasive medical procedures, like a hysterectomy, which carries greater risk and significantly more recovery time. KEY QUOTES: “Gynesonics continues to lay a strong foundation for success, having achieved a number of important commercial milestones in the most recent quarters. The company is very well positioned to continue the acceleration of its growth going forward. Amzak Health and our fellow Gynesonics investors are very excited about the company’s prospects to become the leading long-term solution in the treatment of symptomatic fibroids.” — Joyce Erony, General Partner, Amzak Health “Uterine fibroids cause suffering to millions of women. MVM is glad to support Gynesonics in offering a uterus-preserving, incisionless alternative to hysterectomy and myomectomy.” — Hugo Harrod of MVM Partners “This funding will enable Gynesonics to continue to expand commercial operations and provide millions of patients suffering from symptomatic fibroids a safe and efficacious minimally invasive treatment. With 275M+ U.S. covered lives (including 19 of the top 20 commercial payers) covering Sonata and our new Category 1 code going live in January, we are excited to accelerate our commercial efforts in the U.S. as well as Europe.” — Skip Baldino, President and CEO of Gynesonics Sponsors
Kaiser Permanente Ventures Investments
170 Investments
Kaiser Permanente Ventures has made 170 investments. Their latest investment was in Abridge as part of their Series B on October 10, 2023.

Kaiser Permanente Ventures Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
10/26/2023 | Series B | Abridge | $30M | Yes | 4 | |
6/22/2023 | Series C - II | Everytable | $25M | No | 3 | |
6/21/2023 | Series C | DexCare | $75M | No | 11 | |
4/11/2023 | Series H | |||||
1/31/2023 | Series C |
Date | 10/26/2023 | 6/22/2023 | 6/21/2023 | 4/11/2023 | 1/31/2023 |
---|---|---|---|---|---|
Round | Series B | Series C - II | Series C | Series H | Series C |
Company | Abridge | Everytable | DexCare | ||
Amount | $30M | $25M | $75M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 4 | 3 | 11 |
Kaiser Permanente Ventures Portfolio Exits
41 Portfolio Exits
Kaiser Permanente Ventures has 41 portfolio exits. Their latest portfolio exit was Nuvolo on October 02, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
10/2/2023 | Acquired | 2 | |||
6/1/2022 | Acquired | 3 | |||
8/25/2021 | Merger | 10 | |||
Date | 10/2/2023 | 6/1/2022 | 8/25/2021 | ||
---|---|---|---|---|---|
Exit | Acquired | Acquired | Merger | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 | 3 | 10 |
Kaiser Permanente Ventures Fund History
7 Fund Histories
Kaiser Permanente Ventures has 7 funds, including Kaiser Permanente Ventures V.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
12/5/2019 | Kaiser Permanente Ventures V | Multi-Stage Venture Capital | Closed | $141M | 3 |
6/30/2008 | KP Healthcare Fund V | ||||
10/1/2006 | Kaiser Permanente Healthcare Fund IV | ||||
3/30/2005 | Kaiser Permanente Healthcare Fund III | ||||
7/31/2004 | Kaiser Permanente Healthcare Side Fund |
Closing Date | 12/5/2019 | 6/30/2008 | 10/1/2006 | 3/30/2005 | 7/31/2004 |
---|---|---|---|---|---|
Fund | Kaiser Permanente Ventures V | KP Healthcare Fund V | Kaiser Permanente Healthcare Fund IV | Kaiser Permanente Healthcare Fund III | Kaiser Permanente Healthcare Side Fund |
Fund Type | Multi-Stage Venture Capital | ||||
Status | Closed | ||||
Amount | $141M | ||||
Sources | 3 |
Kaiser Permanente Ventures Partners & Customers
2 Partners and customers
Kaiser Permanente Ventures has 2 strategic partners and customers. Kaiser Permanente Ventures recently partnered with Unite Us on May 5, 2019.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
5/30/2019 | Partner | United States | Event Recap – Community-Wide Collaboration Between the Health Care & Social Sectors - KP Ventures To read more about the Unite Us partnership with Kaiser Permanente Ventures on Thrive Local , please read here . | 1 | |
4/23/2019 | Partner |
Date | 5/30/2019 | 4/23/2019 |
---|---|---|
Type | Partner | Partner |
Business Partner | ||
Country | United States | |
News Snippet | Event Recap – Community-Wide Collaboration Between the Health Care & Social Sectors - KP Ventures To read more about the Unite Us partnership with Kaiser Permanente Ventures on Thrive Local , please read here . | |
Sources | 1 |
Kaiser Permanente Ventures Service Providers
1 Service Provider
Kaiser Permanente Ventures has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Counsel |
Service Provider | |
---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type |
Partnership data by VentureSource
Kaiser Permanente Ventures Team
3 Team Members
Kaiser Permanente Ventures has 3 team members, including current Managing Director, Amy Belt Raimundo.
Name | Work History | Title | Status |
---|---|---|---|
Amy Belt Raimundo | Evidation, Covidien Ventures, Medtronic, Advanced Technology Ventures, and Guidant Global | Managing Director | Current |
Name | Amy Belt Raimundo | ||
---|---|---|---|
Work History | Evidation, Covidien Ventures, Medtronic, Advanced Technology Ventures, and Guidant Global | ||
Title | Managing Director | ||
Status | Current |
Compare Kaiser Permanente Ventures to Competitors
H&S Tech is a manufacturer and distributor of disposable packaging and medical products from South Korea and China. It supplies general to custom products for government sectors, retail sectors, and food distribution sectors. The company delivers within the United States. It was founded in 2019 and is based in Anaheim, California.

Panda Health is a company that operates in the digital health sector, focusing on facilitating connections between health systems and digital health companies. The company offers a platform that aids in the exploration and adoption of leading digital health technologies, providing insights backed by extensive data, solution evaluations, and market intelligence. Panda Health primarily serves the healthcare industry. It was founded in 2020 and is based in Atlanta, Georgia.
Marche Health is a digital health marketplace operating in the healthcare and technology sectors. The company provides a platform for the evaluation and adoption of digital health initiatives, connecting healthcare systems, digital health vendors, healthcare payers, pharmaceutical companies, investors, and consultants. It primarily serves the healthcare industry. It was founded in 2020 and is based in New York, New York.

Zelis operates as a company focusing on modernizing the business of healthcare. It offers a platform that aims to bridge gaps in the healthcare financial system, providing solutions to healthcare networks, ensure regulatory compliance, manage out-of-network costs, and improve payment integrity. It primarily serves the healthcare industry, with key customer segments including healthcare insurers, providers, and consumers. Zelis was formerly known as Stratose. The company was founded in 1995 and is based in Bedminster, New Jersey.

Capital Rx provides a healthcare technology company. It offers a pharmacy benefits management (PBM) platform that reduces administrative costs, improves patient outcomes, and delivers a superior customer experience. It also offers prescription savings cards. The company was founded in 2017 and is based in New York, New York.

Looking for private equity investors for drug development, medical devices, nutraceuticals and healthcare IT technology
Loading...